Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zoetis    ZTS

ZOETIS

(ZTS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/18/2020 11/19/2020 11/20/2020 11/23/2020 11/24/2020 Date
163.5(c) 166.31(c) 166.2(c) 164.34(c) 161.06(c) Last
1 457 816 1 329 244 1 217 711 1 493 220 2 425 927 Volume
-1.17% +1.72% -0.07% -1.12% -2.00% Change
More quotes
Financials (USD)
Sales 2020 6 606 M - -
Net income 2020 1 659 M - -
Net Debt 2020 3 277 M - -
P/E ratio 2020 47,4x
Yield 2020 0,49%
Sales 2021 7 096 M - -
Net income 2021 1 882 M - -
Net Debt 2021 2 436 M - -
P/E ratio 2021 40,2x
Yield 2021 0,56%
Capitalization 76 547 M 76 547 M -
EV / Sales 2020 12,1x
EV / Sales 2021 11,1x
Nbr of Employees 10 600
Free-Float 94,6%
More Financials
Company
Zoetis specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (50.2%): cats and dogs (93.8% of net sales) and horses (6.2%); - livestock (48.4%): cattle (54.6% of sales), swine (20.2%), poultry (18.4%), fish (4.4%) and other (2.4%); - other (1.4%). Net sales break down by family of products into vaccines (23.7%), antiinfectives (20%),... 
Sector
Pharmaceuticals
Calendar
02/09Earnings Release
More about the company
Notations Surperformance© of Zoetis
Trading Rating : Investor Rating :
More Ratings
All news about ZOETIS
11/17ZOETIS : Researchers and Scientists Present at 6th World One Health Congress
PU
11/16ZOETIS : is First Animal Health Company to Issue Environmental, Social and Gover..
BU
11/12ZOETIS : Receives European Commission Marketing Authorization for Librela® (bedi..
BU
11/05Zoetis CFO Boosts Third-Party Orders as Pet Owners Drive Sales
DJ
11/05ZOETIS : Management's Discussion and Analysis of Financial Condition and Results..
AQ
11/05Today on Wall Street: Alibaba, Bristol-Myers Squibb, T-Mobile US…
11/05ZOETIS : Increases Fiscal Year Outlook
DJ
11/05ZOETIS : 3Q Net Profit, Revenue Climb
DJ
11/05ZOETIS : 3Q Earnings Snapshot
AQ
11/05ZOETIS INC. : Results of Operations and Financial Condition (form 8-K)
AQ
11/05ZOETIS : Announces Third Quarter 2020 Results
BU
11/04Soybeans Higher on Brazilian Weather Woes
DJ
11/02ZOETIS : quaterly earnings release
10/26ZOETIS : to Participate in the Credit Suisse 2020 Virtual Healthcare Conference
BU
10/14Pandemic Pets Push Industry Stocks to Pricey Valuations
DJ
More news
News in other languages on ZOETIS
11/05EN DIRECT DES MARCHES : ArcelorMittal, Société Générale, Veolia, CGG, Lufthansa,..
11/05Insoutenable
11/02ZOETIS : Veröffentlichung des Quartalsergebnisses
11/02ZOETIS : publication des résultats trimestriels
08/12Il va y avoir comme un problème
More news
Analyst Recommendations on ZOETIS
More recommendations
Chart ZOETIS
Duration : Period :
Zoetis Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZOETIS
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 180,88 $
Last Close Price 161,06 $
Spread / Highest target 30,4%
Spread / Average Target 12,3%
Spread / Lowest Target -22,4%
EPS Revisions
Managers
NameTitle
Kristin C. Peck Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Roxanne Lagano Chief Human Resources Officer
Glenn C. David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS21.69%76 547
ELANCO ANIMAL HEALTH INCORPORATED7.37%14 922
DECHRA PHARMACEUTICALS PLC9.45%4 581
JINYU BIO-TECHNOLOGY CO., LTD.33.71%4 277
VIRBAC-11.21%2 105
TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD.59.86%1 403